Holen Sie sich die Stockscreener-App
13.49
1.28%
-0.175
Handel nachbörslich:
13.23
-0.26
-1.93%
Schlusskurs vom Vortag:
$13.66
Offen:
$13.55
24-Stunden-Volumen:
23,227
Relative Volume:
0.82
Marktkapitalisierung:
$27.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-43.52
EPS:
-0.31
Netto-Cashflow:
$-3.95M
1W Leistung:
+2.98%
1M Leistung:
-4.87%
6M Leistung:
-17.99%
1J Leistung:
-23.35%
1-Tages-Spanne:
$13.10
$13.63
1-Wochen-Bereich:
$12.71
$13.75
52-Wochen-Spanne:
$8.74
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Firmenname
Cadrenal Therapeutics Inc
Sektor
Branche
Telefon
904-300-0701
Adresse
822 A1A NORTH, PONTE VEDRA
Vergleichen Sie CVKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
13.49 | 27.97M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-18 | Eingeleitet | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten
What the charts say about Cadrenal Therapeutics Inc. todayShort Setup & Weekly Chart Analysis and Guides - newser.com
Why Cadrenal Therapeutics Inc. stock could see breakout soonTreasury Yields & Stepwise Trade Signal Guides - newser.com
Measuring Cadrenal Therapeutics Inc.’s beta against major indicesMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Is Cadrenal Therapeutics Inc. stock cheap compared to fundamentals2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Price momentum metrics for Cadrenal Therapeutics Inc. explained2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Is Cadrenal Therapeutics Inc. trending in predictive chart modelsMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com
Will Cadrenal Therapeutics Inc. see short term momentum2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
What to do if you’re stuck in Cadrenal Therapeutics Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Applying Elliott Wave Theory to Cadrenal Therapeutics Inc.Trade Exit Summary & Verified Entry Point Signals - newser.com
Quantitative breakdown of Cadrenal Therapeutics Inc. recent moveTrade Risk Summary & Safe Entry Momentum Tips - newser.com
What institutional flow reveals about Cadrenal Therapeutics Inc.Trend Reversal & Stepwise Swing Trade Plans - newser.com
Cadrenal Therapeutics Inc Stock Analysis and ForecastEarnings Beat Highlights & The Best Picks Hiding in Plain Sight - earlytimes.in
Applying chart zones and confluence areas to Cadrenal Therapeutics Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Is Cadrenal Therapeutics Inc. stock a good choice for value investors2025 Volatility Report & Verified Entry Point Detection - newser.com
Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030 - Benzinga
Combining machine learning predictions for Cadrenal Therapeutics Inc.July 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Viridian Therapeutics (NASDAQ:VRDN) Director Acquires $9,999,990.00 in Stock - Defense World
Why Cadrenal Therapeutics Inc. stock is rated strong buy2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Insider Sell: Matthew Szot Sells Shares of Cadrenal Therapeutics Inc (CVKD) - GuruFocus
Cadrenal Therapeutics Executives Sell Shares - TradingView
CVKD CFO reports 3,600-share sale; 9,933 shares remain - Stock Titan
CVKD insider Quang Pham reports sales under Rule 10b5‑1 plan - Stock Titan
Can Cadrenal Therapeutics Inc. stock reach $100 price target2025 Trading Recap & Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
History Review: Will Cadrenal Therapeutics Inc. stock outperform value stocksJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Fundação Cultural do Pará
Aug Update: Can Cadrenal Therapeutics Inc. stock outperform in 2025 bull marketMarket Activity Summary & Weekly High Potential Stock Alerts - fcp.pa.gov.br
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):